title: [Goodpasture's syndrome--disease of many faces].
abstract: Pulmonary-renal syndrome (PRS) can originate from several connective tissue diseases. It belongs to the potentially life-threatening conditions. Clinically PRS is a combination of diffuse pulmonary hemorrhage and renal involvement including glomerulonephritis, nephrotic syndrome or acute renal failure. Goodpasture's syndrome accounts for approximately 20% cases of PRS. Until recently diffuse pulmonary hemorrhage connected with rapid progressive glomerulonephritis usually resulted in a very bad prognosis. However now, rapid diagnostic process (antibodies identification, kidney and pulmonary biopsy) can speed up a difficult decision of using intense immunosuppressive therapy including cyclophosphamide and methylprednisolone pulses or plasma exchanges. Simultaneously, the therapy should be supported by artificial ventilation and renal replacement therapy. In some cases such a treatment can be followed by a complete recovery from renal and pulmonary diseases. The combined therapy contributed to considerable reduction in mortality rate that recently has been achieved in PRS patients. In present paper 3 cases of Goodpasture's syndrome with different manifestations of the disease were described.
authors.affiliation: Z Katedry i Kliniki Nefrologii Uniwersytetu Jagielloriskiego Collegium Medicum w Krakowie.
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Panek
authors.forename: Bogusław
authors.initials: B
authors.lastname: Walatek
authors.forename: Władysław
authors.initials: W
authors.lastname: Sułowicz
mesh_terms: D019867:Anti-Glomerular Basement Membrane Disease / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*; D003937:Diagnosis, Differential; D042241:Early Diagnosis; D005921:Glomerulonephritis / Q000175:diagnosis; D006470:Hemorrhage / Q000175:diagnosis; D006801:Humans; D008171:Lung Diseases / Q000175:diagnosis; D008775:Methylprednisolone / Q000008:administration & dosage; D010951:Plasma Exchange; D011379:Prognosis; D017582:Renal Replacement Therapy; D012121:Respiration, Artificial; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D008775:Methylprednisolone